MyFinsight
Home
Blog
About
Cash and cash
equivalents
$1,006,702K
Short-term investments
$351,056K
Accounts receivable, net
$67,011K
Short-term portion of
financial royalty assets,...
$12,982K
Inventory
$10,263K
Other current assets
$6,191K
Income taxes
receivable
$2,911K
Total current assets
$1,457,116K
Intangible assets, net
$209,244K
Long-term portion of
financial royalty assets,...
$194,228K
Other investments
$114,483K
Goodwill
$101,541K
Equity method
investments
$42,390K
Deferred income taxes,
net
$37,119K
Noncurrent derivative
assets
$17,913K
Other assets
$11,841K
Total assets
$2,185,875K
Total liabilities and
stockholders equity
$2,185,875K
Total liabilities
$1,218,359K
Total stockholders
equity
$967,516K
Convertible senior notes,
net
$1,126,594K
Total current
liabilities
$46,736K
Deferred income taxes,
net
$21,654K
Other long-term
liabilities
$17,216K
Long-term operating lease
liabilities
$3,777K
Long-term contingent
liabilities
$2,382K
Retained earnings
$583,251K
Additional paid-in capital
$379,769K
Accumulated other
comprehensive income
$4,476K
Common stock, 0.001 par
value 60,000 shares...
$20K
Accrued liabilities
$31,867K
Accounts payable
$9,405K
Income taxes payable
$3,217K
Current operating lease
liabilities
$1,082K
Other current
liabilities
$955K
Current contingent
liabilities
$210K
Back
Back
Balance Sheet
LIGAND PHARMACEUTICALS INC (LGNYZ)
LIGAND PHARMACEUTICALS INC (LGNYZ)
source: myfinsight.com